Alitretinoin [Toctino; Basilea Pharmaceutica] has been accepted as a treatment for severe chronic hand eczema in Scotland's NHS

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.574, 2009-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alitretinoin: In Severe Chronic Hand Eczema

By Garnock-Jones Karly P.   Perry Caroline M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1625-1634

Adis International

Access to resources Recommend Favorite

Alitretinoin: a guide to its use in severe chronic hand eczema

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal

By Rodgers Mark  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 351-362

Adis International

Access to resources Recommend Favorite

Use of Longitudinal Dose–Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE)

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 4, 2015-04 ,pp. : 255-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

An update on recommendations for the treatment of severe sepsis and septic shock has been released

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite